Home/Zylo Therapeutics/Scott R. Pancoast
SR

Scott R. Pancoast

CEO & Founder

Zylo Therapeutics

Zylo Therapeutics Pipeline

DrugIndicationPhase
AEA for Lupus (w/ Atticus Pharma)Lupus skin lesionsPre-clinical
Follicular Targeting ProgramAcne, AlopeciaResearch/Discovery
Solubility Enhancement ProgramUndisclosedResearch/Discovery
Y100 Mitochondrial BiogenesisSkin rejuvenation/restorationResearch/Discovery